nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.02.2020 | Editorial

A future for PET imaging in Alzheimer’s disease

verfasst von: Aurélie Kas, Raffaella Migliaccio, Bertrand Tavitian

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

Alzheimer’s disease is defined neuropathologically by abnormal extra-cellular β-amyloid plaques combined with intraneuronal tau aggregation (neurofibrillary tangles). Observations showing that patients with different clinical presentations and evolutions share the same neuropathological features have led to the notion of an Alzheimer’s disease spectrum encompassing typical and atypical forms of Alzheimer’s disease [1, 2]. …

Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, et al. Focal cortical presentations of Alzheimer’s disease. Brain. 2007;130:2636–45.CrossRef

Mendez MF. Early-onset Alzheimer disease and its variants: CONTINUUM: Lifelong Learning in Neurology. 2019;25:34–51.

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10:785–96.CrossRef

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.CrossRef

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29.CrossRef

Bera G, Migliaccio R, Michelin T, Lamari F, Ferrieux S, Nogues M, et al. Parietal involvement in the semantic variant of primary progressive aphasia with Alzheimer’s disease cerebrospinal fluid profile. J Alzheimers Dis. 2018.

Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70:327–40.CrossRef

Warren JD, Fletcher PD, Golden HL. The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol. 2012 [cited 2013 Aug 29]; Available from: http://www.nature.com/doifinder/10.1038/nrneurol.2012.135

Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci. 2009;29:1860–73.CrossRef

10.

Migliaccio R, Gallea C, Kas A, Perlbarg V, Samri D, Trotta L, et al. Functional connectivity of ventral and dorsal visual streams in posterior cortical atrophy. J Alzheimers Dis. 2016;51:1119–30.CrossRef

11.

Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, et al. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer’s disease variants. Neurobiol Aging. 2015;36:2678–86.CrossRef

12.

de Souza LC, Corlier F, Habert M-O, Uspenskaya O, Maroy R, Lamari F, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:2036–43.CrossRef

13.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320:1151–62.CrossRef

14.

Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain. 2016;139:1551–67.CrossRef

15.

Sala A, Caprioglio C, Santangelo R, Vanoli EG, Iannaccone S, Magnani G, et al. Brain metabolic signatures across the Alzheimer’s disease spectrum. Eur J Nucl Med Mol Imaging. 2019; (in press).

16.

Migliaccio R, Agosta F, Rascovsky K, Karydas A, Bonasera S, Rabinovici GD, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73:1571–8.CrossRef

17.

Sintini I, Martin PR, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, et al. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer’s disease. NeuroImage Clin. 2019;23:101823.CrossRef

18.

Firth NC, Primativo S, Marinescu R-V, Shakespeare TJ, Suarez-Gonzalez A, Lehmann M, et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain. 2019;142:2082–95.CrossRef

19.

Vanhoutte M, Semah F, Leclerc X, Sillaire AR, Jaillard A, Kuchcinski G, et al. Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2019; Available from: http://link.springer.com/10.1007/s00259-019-04519-w.

20.

Migliaccio R, Federica A, Basaia S, Cividini C, Habert MO, Kas A, et al. Functional brain connectome in posterior cortical atrophy. Neuroimage Clin. in press.

Titel: A future for PET imaging in Alzheimer’s disease
verfasst von: Aurélie Kas
Raffaella Migliaccio
Bertrand Tavitian
Publikationsdatum: 01.02.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04640-w

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

[18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach

Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer’s disease to Parkinson’s disease

Publisher Correction: Artificial intelligence and radiomics in nuclear medicine: potentials and challenges

Striking neurologic 18F-FDG PET/CT pattern in Devic’s disease (neuromyelitis optica spectrum disorder)

Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET”